9267
Genky DrugStores Co.,Ltd.
Ｇｅｎｋｙ ＤｒｕｇＳｔｏｒｅｓ
- Industry
- Retail Trade
- Market
- Prime
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Notes
- Stock adjustmentsJun 21, 2024 Stock split 1 share → 2 shares
Key metrics
Revenue(million JPY)
Jun 2021
142,376
Jun 2022
154,640
Jun 2023
169,059
Jun 2024
184,860
Jun 2025
200,786
Operating profit(million JPY)
Jun 2021
6,295
Jun 2022
5,675
Jun 2023
6,709
Jun 2024
9,015
Jun 2025
9,658
Operating profit margin(%)
Jun 2021
4.42
Jun 2022
3.67
Jun 2023
3.97
Jun 2024
4.88
Jun 2025
4.81
Profit before tax(million JPY)
Jun 2021
6,663
Jun 2022
6,084
Jun 2023
6,704
Jun 2024
8,803
Jun 2025
9,902
Profit(million JPY)
Jun 2021
4,832
Jun 2022
4,421
Jun 2023
4,764
Jun 2024
6,324
Jun 2025
7,066
Total assets(million JPY)
Jun 2021
90,795
Jun 2022
97,118
Jun 2023
105,912
Jun 2024
113,939
Jun 2025
127,326
Cash and cash equivalents(million JPY)
Jun 2021
7,913
Jun 2022
5,438
Jun 2023
5,329
Jun 2024
5,896
Jun 2025
6,221
Cash flows from operating activities(million JPY)
Jun 2021
12,075
Jun 2022
6,076
Jun 2023
8,773
Jun 2024
13,256
Jun 2025
12,597
Cash flows from investing activities(million JPY)
Jun 2021
-8,829
Jun 2022
-10,589
Jun 2023
-9,736
Jun 2024
-10,631
Jun 2025
-15,618
Cash flows from financing activities(million JPY)
Jun 2021
-1,953
Jun 2022
2,038
Jun 2023
854
Jun 2024
-2,058
Jun 2025
3,346
Return on equity(%)
Jun 2021
16.2
Jun 2022
12.9
Jun 2023
12.4
Jun 2024
14.5
Jun 2025
14.2
Equity ratio(%)
Jun 2021
35.4
Jun 2022
37.3
Jun 2023
38.3
Jun 2024
40.9
Jun 2025
41.8
Earnings per share(JPY per share)
Jun 2021
159.175
Jun 2022
145.615
Jun 2023
156.92
Jun 2024
104.105
Jun 2025
232.51
Net assets per share(JPY per share)
Jun 2021
1,058.98
Jun 2022
1,191.705
Jun 2023
1,337.17
Jun 2024
766.405
Jun 2025
1,752.3
Dividend per share(JPY per share)
Jun 2021
12.5
Jun 2022
12.5
Jun 2023
12.5
Jun 2024
12.75
Jun 2025
13
Payout ratio(%)
Jun 2021
7.85
Jun 2022
8.58
Jun 2023
7.97
Jun 2024
12.25
Jun 2025
5.59
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.